683 Capital Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.23M	Sell	130,000 -52,000	-29%	-$1.67M	0.39%	79
2025 Q4	$6.4M	Sell	182,000 -58,000	-24%	-$2.06M	0.53%	68
2025 Q3	$6.31M	Sell	240,000 -14,000	-6%	-$418K	0.57%	63
2025 Q2	$6.73M	Sell	254,000 -51,000	-17%	-$1.34M	0.68%	59
2025 Q1	$7.37M	Buy	305,000 +25,000	+9%	+$790K	0.75%	56
2024 Q4	$11.3M	Sell	280,000 -40,000	-13%	-$2.28M	1.11%	36
2024 Q3	$20.3M	Sell	320,000 -20,000	-6%	-$1.17M	2.06%	15
2024 Q2	$18M	Sell	340,000 -15,000	-4%	-$983K	1.89%	19
2024 Q1	$29.1M	Sell	355,000 -265,000	-43%	-$11.8M	2.97%	12
2023 Q4	$11.5M	Sell	620,000 -5,000	-0.8%	-$65.4K	1.16%	42
2023 Q3	$6.92M	Buy	625,000 +45,000	+8%	+$644K	0.7%	58
2023 Q2	$9.4M	Hold	580,000	–	–	0.91%	42
2023 Q1	$9.66M	Buy	580,000 +551,000	+1,900%	+$5.69M	0.86%	40
2022 Q4	$273K	Buy	+29,000	New	+$129K	0.02%	138